Oppenheimer Asset Management’s Merck MRK Stock Holding History

Oppenheimer Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63.3M	Buy	492,922 +850	+0.2%	+$99.5K	0.66%	28
2026 Q1	$59.2M	Sell	492,072 -10,813	-2%	-$1.25M	0.68%	23
2025 Q4	$52.9M	Sell	502,885 -51,113	-9%	-$4.8M	0.65%	28
2025 Q3	$46.5M	Buy	553,998 +32,959	+6%	+$2.71M	0.51%	37
2025 Q2	$41.2M	Buy	521,039 +43,410	+9%	+$3.45M	0.47%	41
2025 Q1	$42.9M	Sell	477,629 -1,117	-0.2%	-$104K	0.53%	34
2024 Q4	$47.6M	Buy	478,746 +53,953	+13%	+$5.56M	0.58%	28
2024 Q3	$48.2M	Buy	424,793 +42,052	+11%	+$5M	0.58%	33
2024 Q2	$47.4M	Buy	382,741 +55,085	+17%	+$7.1M	0.61%	28
2024 Q1	$43.2M	Sell	327,656 -77,096	-19%	-$9.5M	0.63%	31
2023 Q4	$44.1M	Sell	404,752 -4,678	-1%	-$486K	0.61%	33
2023 Q3	$42.2M	Sell	409,430 -17,857	-4%	-$1.92M	0.65%	32
2023 Q2	$49.3M	Sell	427,287 -10,685	-2%	-$1.21M	0.73%	27
2023 Q1	$46.6M	Sell	437,972 -5,757	-1%	-$622K	0.72%	27
2022 Q4	$49.2M	Sell	443,729 -16,660	-4%	-$1.7M	0.79%	16
2022 Q3	$39.6M	Buy	460,389 +43,168	+10%	+$3.85M	0.7%	24
2022 Q2	$38M	Buy	417,221 +8,089	+2%	+$717K	0.64%	33
2022 Q1	$33.6M	Buy	409,132 +17,645	+5%	+$1.39M	0.48%	38
2021 Q4	$30M	Buy	391,487 +12,227	+3%	+$974K	0.4%	49
2021 Q3	$28.5M	Buy	379,260 +18,170	+5%	+$1.38M	0.41%	51
2021 Q2	$28.1M	Buy	361,090 +26,886	+8%	+$2M	0.4%	53
2021 Q1	$24.6M	Buy	334,204 +9,928	+3%	+$732K	0.38%	58
2020 Q4	$25.3M	Sell	324,276 -22,480	-6%	-$1.72M	0.42%	53
2020 Q3	$27.4M	Buy	346,756 +9,670	+3%	+$757K	0.53%	39
2020 Q2	$24.9M	Sell	337,086 -21,235	-6%	-$1.6M	0.51%	44
2020 Q1	$26.3M	Buy	358,321 +32,132	+10%	+$2.53M	0.65%	31
2019 Q4	$28.3M	Sell	326,189 -53,679	-14%	-$4.41M	0.6%	24
2019 Q3	$30.5M	Sell	379,868 -7,970	-2%	-$639K	0.68%	20
2019 Q2	$31M	Buy	387,838 +3,511	+0.9%	+$269K	0.69%	20
2019 Q1	$30.5M	Sell	384,327 -3,802	-1%	-$284K	0.69%	20
2018 Q4	$28.3M	Buy	388,129 +17,884	+5%	+$1.26M	0.7%	20
2018 Q3	$25.1M	Buy	370,245 +707	+0.2%	+$45K	0.56%	28
2018 Q2	$21.4M	Buy	369,538 +57,081	+18%	+$3.22M	0.52%	32
2018 Q1	$16.2M	Buy	312,457 +7,706	+3%	+$416K	0.41%	52
2017 Q4	$18.6M	Hold	304,751	–	–	0.49%	39
2017 Q3	$18.6M	Buy	304,751 +5,127	+2%	+$311K	0.48%	40
2017 Q2	$18.3M	Sell	299,624 -8,951	-3%	-$545K	0.51%	37
2017 Q1	$18.7M	Buy	+308,575	New	+$18.7M	0.53%	32

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Oppenheimer Asset Management's MRK Position: Q2 2026 in Review

Oppenheimer Asset Management increased its Merck (MRK) stake by 0.17% in Q2 2026, buying an estimated $99.5K and bringing the position to 492,922 shares worth $63.3M. The position accounts for 0.66% of the portfolio, ranked #28.

Oppenheimer Asset Management first reported a position in MRK in Q1 2017 and has held it in 38 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Oppenheimer Asset Management held 492,922 shares of Merck worth $63.3M as of Q2 2026.
Oppenheimer Asset Management bought 850 Merck shares in Q2 2026, an estimated $99.5K.
Merck made up 0.66% of Oppenheimer Asset Management's portfolio in Q2 2026, its #28 holding.
Oppenheimer Asset Management first reported a position in Merck in Q1 2017 and has held it in 38 quarters since.
3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.